{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:21:53Z","timestamp":1792142513441,"version":"4.4.0"},"reference-count":65,"publisher":"BMJ","issue":"6","funder":[{"name":"NIHR South London CLAHRC"},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,4,12]]},"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Severe hypoglycaemia (SH), when blood glucose falls too low to support brain function, is the most feared acute complication of insulin therapy for type 1 diabetes mellitus (T1DM). 10% of people with T1DM contribute nearly 70% of all episodes, with impaired awareness of hypoglycaemia (IAH) a major risk factor. People with IAH may be refractory to conventional approaches to reduce SH, with evidence for cognitive barriers to hypoglycaemia avoidance. This paper describes the protocol for the Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc) study, a trial to assess the impact on hypoglycaemia experience of a novel intervention that addresses cognitive barriers to hypoglycaemia avoidance, compared with an existing control intervention, recommended by the National Institute of Health and Care Excellence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A randomised parallel two-arm trial of two group therapies: HARPdoc versus Blood Glucose Awareness Training, among 96 adults with T1DM and problematic hypoglycaemia, despite attendance at education with or without technology use, in four centres providing specialist T1DM services. The primary outcome will be the SH rate at 12 and\/or 24 months after randomisation to either course. Secondary outcomes include rates of SH requiring parenteral therapy, involving unconsciousness or needing emergency services; hypoglycaemia awareness status, overall diabetes control and quality of life measures. An implementation study to evaluate how the interventions are delivered and how implementation impacts on clinical effectiveness is planned as a parallel study, with its own protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol was approved by the London Dulwich Research Ethics Committee, the Health Research Authority, National Health Service R&amp;D and the Institutional Review Board of the Joslin Diabetes Center in the USA. Study findings will be disseminated to study participants and through peer-reviewed publications and conference presentations, including user groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NCY02940873; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-030356","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T19:11:32Z","timestamp":1588878692000},"page":"e030356","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-5531","authenticated-orcid":false,"given":"Stephanie A","family":"Amiel","sequence":"first","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"},{"name":"Department of Diabetes, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jacob","sequence":"additional","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Lauretta","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Diabetes, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"De Zoysa","sequence":"additional","affiliation":[{"name":"Department of Diabetes, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gonder-Frederick","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Kendall","sequence":"additional","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heller","sequence":"additional","affiliation":[{"name":"School of Medicine and Biomedical Sciences, University of Sheffield Faculty of Medicine Dentistry and Health, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Brooks","sequence":"additional","affiliation":[{"name":"Bournemouth Diabetes and Endocrine Centre, Royal Bournemouth Hospital, Bournemouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Toschi","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Harvard University, Cambridge, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulmini","family":"Kariyawasam","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Guy\u2019s and Saint Thomas' Hospitals NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Potts","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Department of Health Services and Population Research, Institute of Psychiatry Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Healy","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Department of Health Services and Population Research, Institute of Psychiatry Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Diabetes, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Sevdalis","sequence":"additional","affiliation":[{"name":"Centre for Implementation Science, Health Sciences and Population Research Department, Institute of Psychiatry Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-9960","authenticated-orcid":false,"given":"Marietta","family":"Stadler","sequence":"additional","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustabshira","family":"Qayyum","sequence":"additional","affiliation":[{"name":"Diabetes Department, Denmark Hill Campus, King\u2019s College London Faculty of Life Sciences and Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Bakolis","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Department of Health Services and Population Research, Institute of Psychiatry Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Goldsmith","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Department of Health Services and Population Research, Institute of Psychiatry Psychology and Neuroscience, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,16]]},"reference":[{"key":"2025121514292270000_9.6.e030356.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2007.05.003"},{"key":"2025121514292270000_9.6.e030356.2","first-page":"1553","article-title":"Glucose Concentrations of Less Than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the american diabetes association and the european association for the study of diabetes","volume":"4060","author":"International Hypoglycaemia Study Group","year":"2017","journal-title":"Diabetes Care"},{"key":"2025121514292270000_9.6.e030356.3","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1154"},{"key":"2025121514292270000_9.6.e030356.4","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1045815"},{"key":"2025121514292270000_9.6.e030356.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1177-7"},{"key":"2025121514292270000_9.6.e030356.6","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.482"},{"key":"2025121514292270000_9.6.e030356.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0824-8"},{"key":"2025121514292270000_9.6.e030356.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2029"},{"key":"2025121514292270000_9.6.e030356.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0082-6"},{"key":"2025121514292270000_9.6.e030356.10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis","volume":"3","author":"Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121514292270000_9.6.e030356.11","unstructured":"The Healthcare Quality Improvement Partnership NDA. National diabetes audit 2012\u20132013 report 2: complications and mortality, 2015."},{"key":"2025121514292270000_9.6.e030356.12","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2112"},{"issue":"1 Pt 1","key":"2025121514292270000_9.6.e030356.13","first-page":"E67","article-title":"Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction","volume":"260","author":"Mitrakou","year":"1991","journal-title":"Am J Physiol"},{"key":"2025121514292270000_9.6.e030356.14","doi-asserted-by":"publisher","DOI":"10.2337\/diab.32.2.134"},{"key":"2025121514292270000_9.6.e030356.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02413.x"},{"key":"2025121514292270000_9.6.e030356.16","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1579"},{"key":"2025121514292270000_9.6.e030356.17","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S2213-8587(13)70017-2","article-title":"Diabetes and driving","volume":"1","author":"Burki","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121514292270000_9.6.e030356.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2109"},{"key":"2025121514292270000_9.6.e030356.19","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.7.901"},{"key":"2025121514292270000_9.6.e030356.20","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.2.223"},{"key":"2025121514292270000_9.6.e030356.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422367"},{"key":"2025121514292270000_9.6.e030356.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91336-6"},{"key":"2025121514292270000_9.6.e030356.23","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.12.1426"},{"key":"2025121514292270000_9.6.e030356.24","first-page":"402","article-title":"Fanelli CG: Recovery and prevention of hypoglycaemia unawareness in type 1 diabetes mellitus. Diabetes","volume":"15","author":"Bolli","year":"2002","journal-title":"nutrition & metabolism"},{"key":"2025121514292270000_9.6.e030356.25","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0102"},{"key":"2025121514292270000_9.6.e030356.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0030"},{"key":"2025121514292270000_9.6.e030356.27","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.637"},{"key":"2025121514292270000_9.6.e030356.28","first-page":"164","article-title":"Blood glucose awareness training in Dutch type 1 diabetes patients: one-year follow-up","volume":"63","author":"Broers","year":"2005","journal-title":"Neth J Med"},{"key":"2025121514292270000_9.6.e030356.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-005-9026-3"},{"key":"2025121514292270000_9.6.e030356.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02486.x"},{"key":"2025121514292270000_9.6.e030356.31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7339.705"},{"key":"2025121514292270000_9.6.e030356.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277818"},{"key":"2025121514292270000_9.6.e030356.33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"key":"2025121514292270000_9.6.e030356.34","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13561"},{"key":"2025121514292270000_9.6.e030356.35","doi-asserted-by":"publisher","DOI":"10.1177\/193229681100500610"},{"key":"2025121514292270000_9.6.e030356.36","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0090"},{"key":"2025121514292270000_9.6.e030356.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03444.x"},{"key":"2025121514292270000_9.6.e030356.38","doi-asserted-by":"publisher","DOI":"10.1177\/1742395313513911"},{"key":"2025121514292270000_9.6.e030356.39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00592-014-0694-8","article-title":"Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors","volume":"52","author":"Anderbro","year":"2015","journal-title":"Acta Diabetol"},{"key":"2025121514292270000_9.6.e030356.40","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2259"},{"key":"2025121514292270000_9.6.e030356.41","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-1245"},{"key":"2025121514292270000_9.6.e030356.42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.diabres.2015.05.034","article-title":"A qualitative evaluation of DAFNE-HART: a psychoeducational programme to restore hypoglycaemia awareness","volume":"109","author":"Shuttlewood","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"2025121514292270000_9.6.e030356.43","doi-asserted-by":"crossref","unstructured":"Heller S , Lawton J , Amiel S , et al . Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes. Southampton (UK): NIHR Journals Library, 2014.","DOI":"10.3310\/pgfar02050"},{"key":"2025121514292270000_9.6.e030356.44","unstructured":"National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng17\/resources\/type-1-diabetes-in-adults-diagnosis-and-management-1837276469701 (Accessed 18th Sep 2016)."},{"key":"2025121514292270000_9.6.e030356.45","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12441"},{"key":"2025121514292270000_9.6.e030356.46","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.7.697"},{"key":"2025121514292270000_9.6.e030356.47","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.4.517"},{"key":"2025121514292270000_9.6.e030356.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03755.x"},{"key":"2025121514292270000_9.6.e030356.49","unstructured":"Margiotta G , Smith E , Halevy C , et al . Differences in cognitions and behaviours between adults with type 1 diabetes with intact and impaired awareness of hypoglycaemia. Diabetologia 2016. Abstract 84."},{"key":"2025121514292270000_9.6.e030356.50","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1343"},{"key":"2025121514292270000_9.6.e030356.51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2217\/dmt.14.3","article-title":"Assessing hyperglycemia avoidance in people with type 1 diabetes","volume":"4","author":"Singh","year":"2014","journal-title":"Diabetes Management"},{"key":"2025121514292270000_9.6.e030356.52","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.6.754"},{"key":"2025121514292270000_9.6.e030356.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2025121514292270000_9.6.e030356.54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/dme.12824","article-title":"Characterizing problematic hypoglycaemia: iterative design and preliminary psychometric validation of the Hypoglycaemia Awareness Questionnaire (HypoA-Q)","volume":"33","author":"Speight","year":"2016","journal-title":"Diabet Med"},{"key":"2025121514292270000_9.6.e030356.55","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0076"},{"key":"2025121514292270000_9.6.e030356.56","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4679(199111)47:6<756::AID-JCLP2270470605>3.0.CO;2-L"},{"key":"2025121514292270000_9.6.e030356.57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/17434440.2015.1080118","article-title":"Alternative approaches for assessing the socioeconomic benefits of medical devices: a systematic review","volume":"12","author":"Wilkinson","year":"2015","journal-title":"Expert Rev Med Devices"},{"key":"2025121514292270000_9.6.e030356.58","unstructured":"Thornicroft G . An adapted version of the Client Service Receipt Inventory (CSRI; Beecham J & Knapp M. 2001. Costing psychiatric interventions. Measuring mental health needs. 2nd edn. Gaskell, London."},{"key":"2025121514292270000_9.6.e030356.59","unstructured":"Medical Research Council. Developing and evaluating complex interventions: new guidance. 2006 https:\/\/www.mrc.ac.uk\/documents\/pdf\/complex-interventions-guidance\/."},{"key":"2025121514292270000_9.6.e030356.60","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3182408812"},{"key":"2025121514292270000_9.6.e030356.61","doi-asserted-by":"crossref","unstructured":"Soukup T , Hull L , Smith EL , et al . An effectiveness-implementation hybrid type 2 trial evaluating two educational programmes targeting severe hypoglycaemia in people with type 1 diabetes: Implementation study protocol. BMJ Open 2019. under review.","DOI":"10.1136\/bmjopen-2019-030370"},{"key":"2025121514292270000_9.6.e030356.62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00207284.2017.1315587","article-title":"Development and initial validation of the assessment of motivational interviewing groups \u2013 observer scales (AMIGOS)","volume":"68","author":"Wagner","year":"2018","journal-title":"Int J of Group Psychotherapy"},{"key":"2025121514292270000_9.6.e030356.63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/16506073.2010.520731","article-title":"Intraclass correlation associated with therapists: estimates and applications in planning psychotherapy research","volume":"40","author":"Baldwin","year":"2011","journal-title":"Cogn Behav Ther"},{"key":"2025121514292270000_9.6.e030356.64","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0599-y"},{"key":"2025121514292270000_9.6.e030356.65","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1417"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-030356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:29:31Z","timestamp":1765837771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-030356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,16]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/bmjopen-2019-030356"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-030356","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}